Is Stellantis a Good Dividend Stock to Buy Right Now?
Stellantis (NYSE: STLA) isn’t the first name most income investors think of,…
Buy
79
EVER Quote, Financials, Valuation and Earnings
Last price:
$24.51
Seasonality move
:
-4.29%
Day range:
$24.30 - $25.14
52-week range:
$16.63 - $30.03
Dividend yield:
0%
P/E ratio:
24.04x
P/S ratio:
1.58x
P/B ratio:
5.93x
Volume:
553K
Avg. volume:
460.9K
1-year change:
28.31%
Market cap:
$886.6M
Revenue:
$500.2M
EPS (TTM):
$1.02
Analysts' Opinion
-
Consensus RatingEverQuote has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $34.17, EverQuote has an estimated upside of 39.34% from its current price of $24.52.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $30.00 representing -22.35% downside risk from its current price of $24.52.
Fair Value
-
According to the consensus of 6 analysts, EverQuote has 39.34% upside to fair value with a price target of $34.17 per share.
EVER vs. S&P 500
-
Over the past 5 trading days, EverQuote has underperformed the S&P 500 by -6.44% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
EverQuote does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
EverQuote has grown year-over-year revenues for 4 quarters straight. In the most recent quarter EverQuote reported revenues of $166.6M.
Earnings Growth
-
EverQuote has grown year-over-year earnings for 0 quarters straight. In the most recent quarter EverQuote reported earnings per share of $0.21.
Enterprise value:
761.6M
EV / Invested capital:
5.09x
Price / LTM sales:
1.58x
EV / EBIT:
16.60x
EV / Revenue:
1.32x
PEG ratio (5yr expected):
-0.13x
EV / Free cash flow:
10.16x
Price / Operating cash flow:
12.16x
Enterprise value / EBITDA:
14.78x
Gross Profit (TTM):
$554.5M
Return On Assets:
20.87%
Net Income Margin (TTM):
6.64%
Return On Equity:
32.32%
Return On Invested Capital:
32.32%
Operating Margin:
9.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $402.7M | $269.8M | $575.8M | $91.1M | $166.6M | |
| Gross Profit | $378.9M | $248M | $554.5M | $86M | $161.3M | |
| Operating Income | -$24.9M | -$24.2M | $45.9M | $1.8M | $15.9M | |
| EBITDA | -$19.1M | -$18.2M | $51.5M | $3M | $17.1M | |
| Diluted EPS | -$0.66 | -$1.41 | $1.02 | $0.05 | $0.21 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $104.2M | $107M | $84.9M | $95.7M | $194.3M | |
| Total Assets | $135.7M | $170.5M | $160.4M | $135.4M | $232.1M | |
| Current Liabilities | $49.1M | $58.2M | $46.3M | $47.1M | $80.4M | |
| Total Liabilities | $59.7M | $68.1M | $48.8M | $47.1M | $82.6M | |
| Total Equity | $76M | $102.4M | $111.6M | $88.3M | $149.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$13.2M | $8.8M | $79.4M | $10.4M | $23.3M | |
| Cash From Investing | -$4.6M | $9.6M | -$4.5M | -$770K | -$1.1M | |
| Cash From Financing | $441K | $1.4M | $1.4M | $999K | $669K | |
| Free Cash Flow | -$17.8M | $5.2M | $75M | $9.7M | $22.2M | |
EVER
Sector
Market Cap
$886.6M
$85.6M
Price % of 52-Week High
81.65%
67.86%
Dividend Yield
0%
0%
Shareholder Yield
--
3.73%
1-Year Price Total Return
28.31%
-8.03%
Beta (5-Year)
0.332
0.583
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$25.23
200-day SMA
Buy
Level
$21.75
Bollinger Bands (100)
Buy
Level
21.38 - 26.34
Chaikin Money Flow
Buy
Level
16.1M
20-day SMA
Buy
Level
$24.24
Relative Strength Index (RSI14)
Buy
Level
50.83
ADX Line
Sell
Level
13.3
Williams %R
Neutral
Level
-55.73
50-day SMA
Buy
Level
$23.61
MACD (12, 26)
Buy
Level
0.30
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
17.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.9213)
Buy
CA Score
(Annual)
Level (2.4429)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-2.9982)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
Stock Forecast FAQ
In the current month, EVER has received 4 Buy ratings 2 Hold ratings, and 0 Sell ratings. The EVER average analyst price target in the past 3 months is $34.17.
-
Where Will EverQuote Stock Be In 1 Year?
According to analysts, the consensus estimate is that EverQuote share price will rise to $34.17 per share over the next 12 months.
-
What Do Analysts Say About EverQuote?
Analysts are divided on their view about EverQuote share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that EverQuote is a Sell and believe this share price will drop from its current level to $30.00.
-
What Is EverQuote's Price Target?
The price target for EverQuote over the next 1-year time period is forecast to be $34.17 according to 6 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is EVER A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for EverQuote is a Buy. 4 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EVER?
You can purchase shares of EverQuote via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase EverQuote shares.
-
What Is The EverQuote Share Price Today?
EverQuote was last trading at $24.51 per share. This represents the most recent stock quote for EverQuote. Yesterday, EverQuote closed at $24.52 per share.
-
How To Buy EverQuote Stock Online?
In order to purchase EverQuote stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Brookfield Asset Management Stock Be In 1 Year?
On a trailing basis Brookfield earned $1.60 per share over…
AMC Stock Forecast, How High Could It Go in 2025 and Beyond?
AMC Entertainment (NYSE:AMC) has been rising lately after years of…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
83
ARQQ alert for Jun 19
Arqit Quantum [ARQQ] is up 22.6% over the past day.
Sell
47
RGC alert for Jun 19
Regencell Bioscience Holdings [RGC] is down 18.36% over the past day.
Sell
49
QNTM alert for Jun 19
Quantum BioPharma [QNTM] is up 17.61% over the past day.
